Effect of HM910, a novel camptothecin derivative, on the inhibition of multiple myeloma cell growth in vitro and in vivo.

Juan Li; Liwu Fu; Zhencong Huang; Hui Zhang; Yifan Chen; Xu Zhang; Xiaokun Wang; Yudan Ouyang; Wenqiang Zhou; Fang Wang

Effect of HM910, a novel camptothecin derivative, on the inhibition of multiple myeloma cell growth in vitro and in vivo.

Juan Li(Sun Yat-sen University), Liwu Fu(Sun Yat-sen University), Zhencong Huang(Sun Yat-sen University), Hui Zhang(Hubei Provincial Women and Children's Hospital), Yifan Chen(Sun Yat-sen University), Xu Zhang(Center for Cancer Research), Xiaokun Wang(Sun Yat-sen University), Yudan Ouyang(Sun Yat-sen University), Wenqiang Zhou(Fujian University of Traditional Chinese Medicine), Fang Wang(First Affiliated Hospital of Zhengzhou University)

PubMed

January 1, 2015

Cited by 9

|Signal Transduction and Targeted Therapy|2021|1k

Lapatinib (Tykerb, GW572016) Reverses Multidrug Resistance in Cancer Cells by Inhibiting the Activity of ATP-Binding Cassette Subfamily B Member 1 and G Member 2

|Cancer Research|2008|385

Apatinib (YN968D1) Reverses Multidrug Resistance by Inhibiting the Efflux Function of Multiple ATP-Binding Cassette Transporters

|Cancer Research|2010|348

Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers

|Proceedings of the National Academy of Sciences|2014|167

Synergistic activation of p53 by inhibition of <i>MDM2</i> expression and DNA damage

|Proceedings of the National Academy of Sciences|1998|161

Effect of HM910, a novel camptothecin derivative, on the inhibition of multiple myeloma cell growth in vitro and in vivo.

Related Papers